Literature DB >> 16714951

Immunologic resistance after repeated botulinum toxin type a injections for facial rhytides.

Gary Borodic.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16714951     DOI: 10.1097/01.iop.0000217703.80859.a3

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


× No keyword cloud information.
  14 in total

1.  A Phase III Study of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines.

Authors:  Matthias Imhof; Ulrich Kühne
Journal:  J Clin Aesthet Dermatol       Date:  2011-10

2.  [Essential blepharospasm : Practice-oriented therapy with botulinum toxin employing reduced treatment intervals].

Authors:  B Wabbels; P Roggenkämper
Journal:  Ophthalmologe       Date:  2012-01       Impact factor: 1.059

3.  [Treatment of crow's feet with two different botulinum toxin type A preparations in split-face technique].

Authors:  W Prager; E Wissmüller; B Kollhorst; A Böer; I Zschocke
Journal:  Hautarzt       Date:  2011-05       Impact factor: 0.751

4.  Emerging Trends in Botulinum Neurotoxin A Resistance: An International Multidisciplinary Review and Consensus.

Authors:  Wilson W S Ho; Philipp Albrecht; Pacifico E Calderon; Niamh Corduff; David Loh; Michael U Martin; Je-Young Park; Lis S Suseno; Fang-Wen Tseng; Vasanop Vachiramon; Rungsima Wanitphakdeedecha; Chong-Hyun Won; Jonathan N T Yu; Mary Dingley
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-06-20

5.  [Does dilution have an impact on cosmetic results with BoNT/A? Complex-protein-free BoNT/A for treatment of glabella lines].

Authors:  W Prager; I Zschocke; C Reich; L Brocatti; K Henning; V Steinkraus
Journal:  Hautarzt       Date:  2009-10       Impact factor: 0.751

6.  Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines.

Authors:  Gabriele Stengel; Eva Kristina Bee
Journal:  Clin Interv Aging       Date:  2011-11-09       Impact factor: 4.458

7.  Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products.

Authors:  Jürgen Frevert
Journal:  Drugs R D       Date:  2015-03

Review 8.  A comparative assessment of three formulations of botulinum toxin A for facial rhytides: a systematic review and meta-analyses.

Authors:  James P Bonaparte; David Ellis; Jason G Quinn; Mohammed T Ansari; Jessica Rabski; Shaun J Kilty
Journal:  Syst Rev       Date:  2013-06-13

9.  Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines.

Authors:  Welf Prager
Journal:  Clin Pharmacol       Date:  2013-03-12

10.  A successful management of sever gummy smile using gingivectomy and botulinum toxin injection: A case report.

Authors:  Diana Mostafa
Journal:  Int J Surg Case Rep       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.